IPM.ai is an Insights as a Service (IaaS) provider that empowers the world’s leading life sciences companies to better understand and improve the lives of patients through the development and commercialization of precision medicine for specialty and rare diseases. IPM’s system of insight streamlines market assessment, patient finding, treatment journey mapping, healthcare provider discovery, key opinion leader identification and personal brand activation by utilizing granular-level longitudinal analytics, artificial intelligence and machine learning in conjunction with a real world data universe of over 300 million de-identified patients and 65 billion anonymized social determinants of health signals. IPM.ai is part of Real Chemistry, a global healthcare innovation company. More than a name, Real Chemistry is a belief system that the way to real, transformative change is through the uncommon combination of talents, disciplines, and technologies. To create entirely new, more intuitive ways to solve problems. With a skillful mix of data, analytics, and the ancient art of human interaction, we know our audiences better than they know themselves. Allowing us to see the unseen, reach the unreachable, and connect the dots, with creative ideas that truly “get” them. Motivating and inspiring to make informed, healthier choices. From clinical to commercial to corporate, we shift the focus from “what is” to “what could be”. Shaping the future of health, by creating real chemistry between people and the brands born to change their lives.
IPM.ai Address
100 Campus Dr Cambridge, MA United States
IPM.ai Email
Past Companies
IPM.aiExecutive Director of Sales
Target RWE Health Evidence SolutionsDirector, Business Development